The effect of aniracetam on cerebral glucose metabolism in rats after lesioning of the basal forebrain measured by PET

Journal of the Neurological Sciences

Volumn 164, Issue 1, 1999, Pages 7-12

  Ouchi, Yasuomi ^a   Kakiuchi, Takeharu ^b   Okada, Hiroyuki ^b   Nishiyama, Shingo ^b   Tsukada, Hideo ^b  

^a HAMAMATSU MEDICAL CENTER   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Aniracetam; Basal forebrain; Cerebral glucose metabolism; Choline acetyltransferase; Ibotenic acid; Positron emission tomography; Rat

Indexed keywords

ANIRACETAM; CHOLINE ACETYLTRANSFERASE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FRONTAL CORTEX; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; MALE; METABOLIC RATE; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

EID: 0033559297     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00036-2     Document Type: Article

References (41)

1. Johnston M.V., McKinney M., Coyle J.T. Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res. 43:1981;159-172.
2. London E.D., McKinney M., Dam M., Ellis A., Coyle J.T. Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus. J Cereb Blood Flow Metab. 4:1984;381-390.
3. Orzi F., Diana G., Casamenti F., Palombo E., Fieschi C. Local cerebral glucose utilization following unilateral and bilateral lesions of the nucleus basalis magnocellularis in the rat. Brain Res. 462:1988;99-103.
4. Ouchi Y., Fukuyama H., Ogawa M., Yamauchi H., Kimura J., Magata Y., Yonekura Y., Konishi J. Cholineric projection from the basal forebrain and cerebral glucose metabolism in rats: a dynamic PET study. J Cereb Blood Flow Metab. 16:1996;34-41.
5. Boatell M.L., Bendahan G., Mahy N. Time-related cortical amino acid changes after basal forebrain lesion: a microdialysis study. J Neurochem. 64:1995;285-291.
6. Gomeza J., Aragon C., Gimenez C. High-affinity transport of choline and amino acid neurotransmitters in synaptosomes from brain regions after lesioning the nucleus basalis magnocellularis of young and aged rats. Neurochem Res. 17:1992;345-350.
7. Cumin R., Bandle E.F., Gamzu E., Haefely W.E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacol. 78:1982;104-111.
8. Kubota A Hayashi T Sakagami T Watanabe A Nakamura K. Scopolamine model of retrograde amnesia: its prevention and relevant cerebral nuclei involved. Proceedings of a Symposium on the pharmacology of learning and memory :1981;96-118 Excerpta Medica, Amsterdam.
9. Vincent G., Verderese A., Gamzu E. The effects of aniracetam (Ro 13-5057) on the enhancement and protection of memory. Ann New York Acad Sci. 444:1985;489-491.
10. Zajaczkowski W., Danysz W. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Pharmacol Biochem Behav. 56:1997;21-29.
11. Frostl W., Maitre L. The families of cognition enhancers. Pharmacopsychiatry. 22:1989;54-100.
12. Senin U., Abate G., Fieschi G., Gori G., Guala A., Marini G., Villardita C., Parnelti L. Aniracetam (Ro-5057) in the treatment of senile dementia of Alzheimer's type (SDAT): results of a placebo controlled multicenter clinical study. Eur Neuropsychopharmacol. 1:1991;511-517.
13. Giovannini M.G., Rodino P., Mutolo D., Pepeu G. Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo. Drug Development Res. 28:1993;503-509.
14. Copani A., Genazzani A.A., Aleppo G., Gasabona G., Canonico P.L., Scapagnini U., Nicoletti F. Nootropic drugs positively modulate a-amino-3-hydroxy-5-methyl-4-isoxazolepropinonic acid-sensitive glutamate receptors in neuronal cultures. J Neurochem. 58:1992;1199-1204.
15. 3H]aniracetam binds to specific recognition sites in brain membranes. J Neurochem. 65:1995;912-918.
16. Isaacson J.S., Nicoll R.A. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci U.S.A. 88:1991;10936-10940.
17. Ito I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol. 424:1990;533-543.
18. Nicoletti F., Casabona G., Genazzani A.A., Copani A., Aleppo G., Canonico P.L., Scapagnini U. Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel sybstrate for the action of nootropic drugs. Funct Neurol. 7:1992;413-422.
19. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
20. Ouchi Y., Okada H., Kakiuchi T., Nishiyama S., Futatsubasi M., Tsukada H., Nobezawa S. Co-registration between PET and MRI in rat brain. Ann Nucl Med. 10:1996;S143.
21. Ouchi Y., Tsukada H., Kakiuchi T., Nishiyama S., Futatsubashi M. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med. 39:1998;198-202.
22. Watanabe M., et al. A High Resolution PET for Animal studies. IEEE Trans Med Imaging. 11:1992;577-580.
23. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem. 24:1975;407-409.
24. Haba K., Ogawa N., Kawata M., Mori A. A method for parallel determination of choline acetyltransferase and muscarinic cholinergic receptors: application in aged-rat brain. Neurochem Res. 13:1988;951-959.
25. Baron J.C., Miyazawa H. Use of positron emission tomography to assess effects of brain lesions in experiment subhuman primates. Michaelconn P. Methods in neurosciences. 1991;429-441 Academic Press, San Diego.
26. Saper C.B. Organization of cerebral cortical afferent systems in the rat. II. Magnocellularis basal nucleus. J Comp Neurol. 222:1984;313-342.
27. Iyo M., Namba H., Fukushi K., Shinotoh H., Nagatsuka S., Suhara T., Sudo Y., Suzuki K., Irie T. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet. 349:1997;1805-1809.
28. Ingvar M., Eriksson L., Rogers G.A., Stone E.S., Widen L. Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis. J Cereb Blood Flow Metab. 11:1991;926-931.
29. Lear J.L., Ackerman R.F. Regional comparison of the lumped constants of deoxyglucose and fluorodeoxyglucose. Metab Brain Dis. 4:1989;95-104.
30. Le Mestric C., Chavoix C., Chapon F., Mezenge F., Epelbaum J., Baron J.C. Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion. J Cereb Blood Flow Metab. 18:1998;476-490.
31. Markram H., Segal M. Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine. J Physiol. 427:1990;381-393.
32. Aoki C., Kabak S. Cholinergic terminals in the cat visual cortex: ultrastructural basis for interaction with glutamate-immunoreactive neurons and other cells. Vis Neurosci. 8:1992;177-191.
33. Giovannini M.G., Camilli F., Mundula A., Pepeu G. Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem Int. 25:1994;23-26.
34. 192IgG-saporin lesions of the basal forebrain. Neuroscience. 77:1997;649-659.
35. 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 696:1995;165-176.
36. Fukuyama H., Ouchi Y., Matsuzaki S., Ogawa M., Yamauchi H., Nagahama Y., Kimura J., Yonekura Y., Shibasaki H., Tsukada H. Focal cortical blood flow activation is regulated by intrinsic cortical cholinergic neurons. Neuroimage. 3:1996;195-201.
37. Cossette P., Umbriaco D., Zamar N., Hemel E., Descarries L. Recovery of choline acetyltransferase activity without sprouting of the residual acetylcholine innervation in adult rat cerebral cortex after lesion of the nucleus basalis. Brain Res. 630:1993;195-206.
38. Lamour Y., Dutar P., Jobert A. Excitatory effect of acetylcholine on different types of neurons in the first somatosensory neocortex of the rat: Laminar distribution and pharmacological characteristics. Neuroscience. 7:1982;1483-1494.
39. Sconcrant T.T., Holloway H.W., Horwitz B., Rapoport S.I., Lamour Y.A. Effect of nucleus basalis magnocellularis abration on local brain glucose utilization in the rat: functional brain reorganization. Eur J Neurosci. 4:1992;653-662.
40. Rossner S., Schliebs R., Bigl V. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 668:1994;85-99.
41. 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Progr Brain Res. 109:1996;253-264.